WebNews

Please enter a web search for web results.

NewsWeb

Carroll Broadcasting Company
1380kcim. com > 05/27/2026 > eli-lilly-steps-into-vaccine-development-with-3-83b-triple-takeover

Eli Lilly steps into vaccine development with $3. 83 B triple takeover

6+ hour, 10+ min ago  (389+ words) Eli Lilly and Company is pivoting significantly toward infectious disease prevention by executing agreements to buy three distinct vaccine developers. Funded by the massive financial windfalls from its dominant obesity and diabetes medications, the Indianapolis-based pharmaceutical giant Wendl's Weapons Straight…...

Symbols: nyse:lly
The Manila Times
manilatimes. net > 05/27/2026 > tmt-newswire > globenewswire > zapatas-harvard-quantum-lab-co-founders-drs-cao-and-olson-return-as-cto-and-vp-of-strategy-and-operations > 2352609

Zapata's Harvard Quantum Lab Co-Founders Drs. Cao and Olson Return as CTO and VP of Strategy and Operations

9+ min ago  (375+ words) Cao rejoins following tenure as Head of Quantum at BCG X; Olson is one of the few IP attorneys globally who also has a background in theoretical physics. .. Zapata's Harvard Quantum Lab Co-Founders Drs. Cao and Olson Return as CTO…...

Symbols: otc:zpta
The White House
whitehouse. gov > research > 2026 > 05 > savings-from-most-favored-nation-drug-pricing-policy

Savings from Most-Favored-Nation Drug Pricing Policy

3+ week, 1+ day ago  (497+ words) The Trump Administration has designed a Most-Favored-Nation (MFN) drug pricing policy framework to address the major differences in drug prices and contributions to the pharmaceutical innovation. .. Savings from Most-Favored-Nation Drug Pricing Policy The Trump Administration has designed a Most-Favored-Nation (MFN)…...

Symbols: btc-usd
pharmabiz. com
pharmabiz. com > News Details. aspx

Biocytogen introduces AI-powered Ren Super platform and industry-first fully automated antibody discovery infrastructure

15+ hour, 46+ min ago  (111+ words) Beijing, China Wednesday, May 27, 2026, 18: 00 Hrs [IST] Bi. .. Biocytogen introduces AI-powered Ren Super platform and industry-first fully automated antibody discovery infrastructure Biocytogen, a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, announced the…...

Symbols: btc-usd
markets. businessinsider. com
markets. businessinsider. com > news > stocks > palvella-therapeutics-to-present-qtorin-rapamycin-results-from-phase-3-selva-and-phase-2-toiva-studies-at-the-international-society-for-the-study-of-vascular-anomalies-world-congress-2026-1036037533

Palvella Therapeutics to Present QTORIN" Rapamycin Results from Phase 3 SELVA and Phase 2 TOIVA Studies at the International Society for the Study of Vascular Anomalies World Congress 2026

1+ mon, 1+ week ago  (248+ words) James Treat, MD, Professor of Clinical Pediatrics and Dermatology at the Children's Hospital of Philadelphia to present clinical results on Wednesday, May 20, 2026, at 4: 30 p. m. ET WAYNE, Pa. , April. .. Palvella Therapeutics to Present QTORIN" Rapamycin Results from Phase 3 SELVA and Phase 2 TOIVA…...

Symbols: nasdaq:pvla
CNBC
cnbc. com > 04/27/2026 > crispr-gene-editing-intellia-trial. html

Intellia Therapeutics says its Crispr-based treatment succeeds in pivotal trial

1+ mon, 2+ hour ago  (449+ words) Intellia Therapeutics said its Crispr-based treatment for a rare swelling condition met its goals in a late-stage trial, marking a milestone for the field of gene editing and putting the company on track to seek approval from the U. S. Food and…...

Symbols: attr-cm,lonvo-z,nasdaq:ntla
The Globe and Mail
theglobeandmail. com > investing > markets > stocks > CRDL > pressreleases > 1801380 > cardiol-therapeutics-phase-ii-maveric-pericarditis-data-accepted-by-jaha-as-phase-iii-trial-nears-completion

Cardiol Therapeutics" Phase II MAv ERIC Pericarditis Data Accepted by JAHA as Phase III Trial Nears Completion

2+ week, 5+ day ago  (134+ words) Cardiol Therapeutics ( (TSE: CRDL) ) has issued an update. The most recent analyst rating on (TSE: CRDL) stock is a Buy with a C$8. 00 price target. To see the full list of analyst forecasts on Cardiol Therapeutics stock, see the TSE:…...

Symbols: nasdaq:crdl
Yahoo Finance
finance. yahoo. com > sectors > healthcare > articles > ginkgo-datapoints-tangible-scientific-inductive-163300116. html

Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One: a High-Throughput ADME Platform That Brings Pharmacokinetic Projection Earlier in Drug Discovery

1+ day, 43+ min ago  (93+ words) A Single, Integrated Workflow Across Three Category Leaders Ginkgo Datapoints: Data Generation. All five Tier 1 assays (microsomal stability, cell permeability, kinetic solubility, CYP inhibition, and plasma protein binding) are executed end-to-end in Ginkgo's automated laboratory in Boston. Validated, standardized workflows…...

Symbols: btc-usd
markets. businessinsider. com
markets. businessinsider. com > news > stocks > agc-biologics-to-manufacture-teikoku-seiyaku-s-rhmmp-7-drug-substance-1036192502

AGC Biologics to Manufacture Teikoku Seiyaku's rh MMP-7 Drug Substance

1+ day, 15+ hour ago  (291+ words) HEIDELBERG, Germany and CHIBA, Japan, May 26, 2026 (GLOBE NEWSWIRE) -- AGC Biologics, your friendly CDMO expert, was selected by Teikoku Seiyaku Co. , Ltd. , a leader in transdermal drug delivery, to provide microbial contract development and manufacturing services for KTP-001, a recombinant human…...

Symbols: rhmmp-7
markets. businessinsider. com
markets. businessinsider. com > news > stocks > traws-pharma-announces-antiviral-program-targeting-ongoing-hantavirus-and-ebola-virus-disease-outbreaks-1036197994

Traws Pharma Announces Antiviral Program Targeting Ongoing Hantavirus and Ebola Virus Disease Outbreaks

2+ hour, 31+ min ago  (160+ words) Utilizing a novel dual-strike mechanism, the proprietary combination agent has the potential to deliver a low pill burden option to manage existing and future outbreaks Interactions planned with the US Centers for Disease Control and Prevention (CDC), and ongoing with the…...

Symbols: nasdaq:traw,asx:ila